7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
9.31%
SONIC FOUNDR SOFO
7.77%
TRI TECH HOL TRIT
6.62%
A M R CP AAMRQ
4.52%
FLOWERS FOOD FLO
4.31%

Equifax Upgraded to Outperform

by Zacks Equity Research

December 26, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

We have upgraded our long-term recommendation on Equifax Inc. ( EFX - Analyst Report ) to Outperform from Neutral based on the company’s upbeat third quarter 2012 results and market share gains in its mortgage solutions portfolio.

Equifax generated strong revenues in its third quarter of 2012 on the back of 35.0% year-over-year growth in Mortgage Solutions revenue. The company also expects mortgage activities to maintain momentum in the coming quarters as home sales should continue to trend up. Equifax noticed market share gains in the mortgage sector, aided by its newly-launched products and services. Hence, it is expected that strength in its mortgage solutions portfolio will be a key catalyst in the near term.

Better mortgage activities and strong performance of non-mortgage revenues led to 16.0% year-over-year growth in earnings per share of 75 cents.

Though the fourth quarter guidance was not very encouraging, we believe that there is adequate growth potential given Equifax’ expanding geographical reach and the recent takeover of Computer Sciences Corp.’s ( CSC - Analyst Report ) Credit Services business. As Equifax had been handling CSC’s business for many years, it will take lesser time to integrate the business within its USCIS segment. The deal will be accretive to earnings per share in 2013.

Headquartered in Atlanta, Georgia, Equifax is one of the leaders in facilitating and securing commerce through proprietary databases containing information on approximately 400 million consumers and businesses worldwide. Equifax helps businesses to identify customers largely based on credit profiles and to reach out to them.

We believe that Equifax’s leading market position in North America and Europe could give the shares a boost going forward. We also think Equifax’ growing exposure in Brazil, which is one of the faster-growing markets in the world, is encouraging. To tap the immense growth opportunity in the Brazilian credit data market, Equifax merged credit reporting operations of its Brazilian subsidiary with Boa Vista Servicos S.A., the second-largest consumer credit bureau in Brazil. But Equifax may face some problem with market share gains of its archrival Experian plc in Brazil.

Overall, we see the company’s service tie-ups with a wide range of industries, lesser customer concentration risks and improving mortgage situation in the U.S. to be positive.

Estimate Revision Trend

Over the last 60 days, all the 11 estimates for fiscal 2012 were raised. Also, 8 out of the 11 estimates were moved upward for fiscal 2013. The magnitude of estimate increased by a penny to $2.95 for fiscal 2012, but was up 34 cents to $3.54 for fiscal 2013 in the last 60 days.

Currently, Equifax has a Zacks #2 Rank (Buy).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.